Reply to “Obesity as a potential confounder of clozapine-induced myocarditis in the Hunter Region of Australia”
Schizophrenia Research · 2024
DOI: 10.1016/j.schres.2024.03.005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Srinivasan Tirupati und 1 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatric Rehabilitation Service Hunter New England Mental Health Morisset, NSW 2264, Australia; School of Medicine and Public Health Faculty of He…. Hauptthemen laut MEDLINE: Clozapine, Myocarditis, Antipsychotic Agents, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Psychiatric Rehabilitation Service Hunter New England Mental Health Morisset, NSW 2264, Australia; School of Medicine and Public Health Faculty of Health, The University of Newcastle Callaghan, NSW 2308, Australia. Elec…
- Psychiatric Rehabilitation Service Hunter New England Mental Health Morisset, NSW 2264, Australia.
Zitieren
APA
Tirupati, S., & Arachchi, M. K. (2024). Reply to “Obesity as a potential confounder of clozapine-induced myocarditis in the Hunter Region of Australia”. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.03.005
Vancouver
Tirupati S, Arachchi MK. Reply to “Obesity as a potential confounder of clozapine-induced myocarditis in the Hunter Region of Australia”. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.03.005
BibTeX
@article{Tirupati2024,
author = {Tirupati, Srinivasan and Arachchi, Mahinda K},
title = {Reply to “Obesity as a potential confounder of clozapine-induced myocarditis in the Hunter Region of Australia”},
journal = {Schizophrenia Research},
year = {2024},
doi = {10.1016/j.schres.2024.03.005}
}
EUVIMED